circFGD4 suppressed GC progression through sponging miR-532-3p and enhancing APC expression to inactivate the beta-catenin signalling. Thus circFGD4 provides a novel potential biomarker and valuable therapeutic strategy for GC.
Circular RNA circFGD4 suppresses gastric cancer progression via modulating miR-532-3p/APC/beta-catenin signalling pathway.